Findings

What do systematic reviews say?

4,720 questions · 15,377 findings · 900 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 3,865 · 25.1%GRADE not reported 2,291 · 14.9%Very low 3,875 · 25.2%Low 3,287 · 21.4%Moderate 1,681 · 10.9%High 378 · 2.5%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Telemedicine vs usual care

All‐cause mortality

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Telemedicine vs usual care

Treatment satisfaction

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Telemedicine vs usual care

HbA1c (%)

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 85 participants
Very low

Patient education vs usual care

Hypoglycaemic episodes a) Non‐serious hypoglycaemia

It is very uncertain whether patient education changes hypoglycaemic episodes (a) Non‐serious hypoglycaemia compared with usual care (very low certainty).

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
RR 1.17 [0.82, 1.66]
2 studies · 377 participants
Very low

Patient education vs usual care

Health‐related quality of life

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

DPP‐4 inhibitors vs sulphonylureas

All‐cause mortality

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 2426 participants
Moderate

Patient education vs usual care

Adverse events other than hypoglycaemia

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Patient education vs usual care

All‐cause mortality

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Patient education vs usual care

Treatment satisfaction

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Patient education vs usual care

HbA1c (%)

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 422 participants
Very low

Drug dosage reduction vs usual care

Hypoglycaemic episodes a) Non‐serious hypoglycaemia

It is very uncertain whether drug dosage reduction changes hypoglycaemic episodes (a) Non‐serious hypoglycaemia compared with usual care (very low certainty).

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
RR 0.18 [0.11, 0.3]
1 study · 678 participants
Very low

Drug dosage reduction vs usual care

Health‐related quality of life

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Drug dosage reduction vs usual care

Adverse events other than hypoglycaemia

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 678 participants
Very low

Drug dosage reduction vs usual care

All‐cause mortality

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Drug dosage reduction vs usual care

Treatment satisfaction

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Drug dosage reduction vs usual care

HbA1c (%)

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

DPP‐4 inhibitors vs sulphonylureas

Treatment satisfaction

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

DPP‐4 inhibitors vs sulphonylureas

HbA1c (%)

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 626 participants
Very low

DPP‐4 inhibitors vs sulphonylureas

Self‐care

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Meglitinides vs sulphonylureas

Hypoglycaemic episodes a) Non‐serious hypoglycaemia

It is very uncertain whether meglitinides changes hypoglycaemic episodes a) Non‐serious hypoglycaemia compared with sulphonylureas (very low certainty).

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
RR 0.72 [0.4, 1.28]
2 studies · 273 participants
Very low